DaVita Inc. provides kidney dialysis services through a network of 2,753 outpatient dialysis centers in the United States, serving 206,900 patients, and 259 outpatient dialysis centers in 10 other countries serving 28,700 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. The company is ranked 188th on the Fortune 500.

Property Value
dbo:abstract
  • DaVita Inc. provides kidney dialysis services through a network of 2,753 outpatient dialysis centers in the United States, serving 206,900 patients, and 259 outpatient dialysis centers in 10 other countries serving 28,700 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. In 2019, 69% of the company's revenues came from Medicare and other government-based health insurance programs. In 2019, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 31% of revenues in 2019, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 188th on the Fortune 500. The name "DaVita" is derived from the Italian language phrase "Dare Vita", which means "giving life". (en)
dbo:assets
  • 1.7311E10
dbo:equity
  • 2.133E9
dbo:foundingYear
  • 1979-01-01 (xsd:date)
dbo:headquarter
dbo:industry
dbo:keyPerson
dbo:netIncome
  • 8.1E8
dbo:numberOfEmployees
  • 65000 (xsd:integer)
dbo:owner
dbo:owningCompany
dbo:revenue
  • 1.1388E10
dbo:service
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 53742105 (xsd:integer)
dbo:wikiPageLength
  • 11443 (xsd:integer)
dbo:wikiPageRevisionID
  • 986425293 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assets
  • 1.7311E10
dbp:bloomberg
  • DVA:US (en)
dbp:equity
  • 2.133E9
dbp:google
  • DVA (en)
dbp:homepage
dbp:hqLocation
dbp:imageCaption
  • DaVita Inc.'s headquarters in Denver, as seen from the Millennium Bridge (en)
dbp:industry
dbp:keyPeople
  • Javier J. Rodriguez, CEO (en)
  • Peter Grauer, lead independent director (en)
dbp:name
  • DaVita Inc. (en)
dbp:netIncome
  • 8.1E8
dbp:numEmployees
  • 65000 (xsd:integer)
dbp:owner
  • Berkshire Hathaway 23.18% (en)
dbp:reuters
  • DVA.N (en)
dbp:revenue
  • 1.1388E10
dbp:secCik
  • DVA (en)
dbp:services
dbp:stockrow
  • DVA (en)
dbp:symbol
  • DVA (en)
dbp:tradedAs
  • S&P 500 Index component (en)
  • NYSE:DVA (en)
dbp:type
dbp:wikiPageUsesTemplate
dbp:yahoo
  • DVA (en)
dct:subject
rdf:type
rdfs:comment
  • DaVita Inc. provides kidney dialysis services through a network of 2,753 outpatient dialysis centers in the United States, serving 206,900 patients, and 259 outpatient dialysis centers in 10 other countries serving 28,700 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. The company is ranked 188th on the Fortune 500. (en)
rdfs:label
  • DaVita Inc. (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • DaVita Inc. (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of